Corbus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $703 | $0 |
Gross Profit | -100 | -100 | -146 | -200 |
EBITDA | -17,562 | -16,897 | -9,384 | -13,250 |
EBIT | -17,662 | -16,978 | -9,530 | -13,402 |
Net Income | -17,662 | -16,978 | -9,530 | -13,783 |
Net Change In Cash | 0 | 0 | 703 | 0 |
Free Cash Flow | -16,599 | -16,421 | -10,942 | -13,942 |
Cash | 20,044 | 18,900 | 17,198 | 19,423 |
Basic Shares | 12,240 | 12,202 | 12,179 | 12,014 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $881 |
Gross Profit | -600 | -31,167 | -1,487 | -757 |
EBITDA | -37,737 | -44,436 | -38,726 | -54,970 |
EBIT | -38,337 | -45,077 | -40,214 | -56,609 |
Net Income | -40,209 | -44,603 | -55,833 | -45,552 |
Net Change In Cash | 0 | 0 | 0 | 881 |
Free Cash Flow | -41,794 | -36,100 | -37,557 | -48,237 |
Cash | 17,198 | 13,723 | 17,002 | 25,006 |
Basic Shares | 10,915 | 4,327 | 4,170 | 4,099 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$1.44 |
2025-03-31 | -$1.39 |
2024-12-31 | -$0.78 |
2024-09-30 | -$1.15 |
